API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206233
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-22-2021-1632297403.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-21-2021-1619072775.pdf
https://www.pharmaceutical-technology.com/news/astrazeneca-divests-atacand-cheplapharm/
https://www.astrazeneca.com/media-centre/press-releases/2021/atacand-divestment-in-over-70-countries-completed.html#:~:text=AstraZeneca%20has%20completed%20the%20divestment,Cheplapharm%20Arzneimittel%20GmbH%20(Cheplapharm)
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-23-2019-1548227584.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210302
https://www.ema.europa.eu/documents/press-release/valsartan-mylan-laboratories-india-can-no-longer-be-used-eu-medicines-due-ndea-impurity_en.pdf
https://www.ema.europa.eu/documents/press-release/eu-authorities-take-further-action-ongoing-review-sartans_en.pdf
https://www.pharmacompass.com/pdf/news/Health-Canada-finds-Zhejiang-Huahai-Pharmaceuticals-site-non-compliant-with-GMP-1538639316.pdf
https://www.pharmacompass.com/pdf/news/EMA-review-of-impurities-in-sartan-medicines-1538045187.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207455
https://www.prnewswire.com/news-releases/ani-pharmaceuticals-acquires-four-ndas-from-astrazeneca-for-465-million-300576084.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203466
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091390
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203813
http://portal.anvisa.gov.br/wps/content/anvisa+portal/anvisa/sala+de+imprensa/menu+-+noticias+anos/201616/anvisa+suspende+lotes+de+medicamento+para+hipertensao+arterial
http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0659-2016&w=02172016&lang=eng
http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0660-2016&w=02172016&lang=eng
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2015/53497r-eng.php
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2015/53251r-eng.php
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2015/52887r-eng.php
http://www.biospace.com/News/nova-southeastern-university-researcher-discovers/363202/source=MoreNews
http://nsunews.nova.edu/nsu-researcher-discovers-certain-arb-drugs-are-more-effective-than-others-at-treating-heart-failure/
http://blogs.wsj.com/pharmalot/2015/01/23/ema-recommends-hundreds-of-drugs-to-be-suspended-over-flawed-studies/
http://www.pharmafile.com/news/502118/takeda-and-teva-set-out-generics-joint-venture-plan?
http://in.reuters.com/article/2014/12/15/us-india-pharmaceuticals-germany-idINKBN0JT13P20141215